title: Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle.
abstract: BACKGROUND
  The tafazzin gene (TAZ) is located at Xq28 and encodes a protein involved in the transacylation of cardiolipin, an essential mitochondrial phospholipid. Mutations in TAZ are associated with Barth syndrome (BTHS), the X-linked recessive condition with dilated cardiomyopathy, skeletal myopathy, growth retardation, neutropenia and organic aciduria. TAZ mutations also contribute to left ventricular noncompaction (LVNC), a cardiomyopathy characterized by loose, trabeculated myocardium.
  
  
  METHODS
  We report a family with a novel TAZ mutation and the clinical spectrum from severe BTHS in an infant to skeletal myopathy with LVNC in an adult, the oldest individual with BTHS reported. The proband is a 51-year-old male with muscle weakness since early childhood. He remained stable until the age of 43. His initial evaluations found LVNC and borderline neutropenia with no elevation of urine 3-methylglutaconic acid. The proband's great nephew is a 3-year-old who presented at birth with poor feeding, hypotonia, lactic acidosis and hypoglycemia. At three months he was admitted with failure to thrive, lethargy and respiratory distress due to heart failure. Cardiac studies revealed dilated cardiomyopathy with a spongiform trabeculated pattern of the left ventricle. Laboratory studies showed cyclic neutropenia and elevated urine 3-methylglutaconic and 3-methylglutaric acids. At age 11months the patient had a heart transplant. We conducted sequence analysis of the TAZ gene for two affected individuals, the proband first and then his great-nephew. A novel, hemizygous nonsense mutation in TAZ exon 7 (c.583G>T, p.Gly195X) was detected.
  
  
  CONCLUSIONS
  At his current age of 51years-old, the proband is the oldest surviving individual reported with a confirmed molecular diagnosis and features of Barth syndrome. Further studies will be conducted to identify the genetic modifying factor(s) associated with the wide phenotypic range seen in this family.
authors.affiliation: UC Irvine Cardiogenomics Program, University of California, Irvine, School of Medicine, Irvine, CA 92697‐3940, USA.
authors.forename: Diti
authors.initials: D
authors.lastname: Ronvelia
authors.forename: Jaclyn
authors.initials: J
authors.lastname: Greenwood
authors.forename: Julia
authors.initials: J
authors.lastname: Platt
authors.forename: Simin
authors.initials: S
authors.lastname: Hakim
authors.forename: Michael V
authors.initials: MV
authors.lastname: Zaragoza
mesh_terms: D000217:Acyltransferases; D056889:Barth Syndrome / Q000235:genetics* / Q000473:pathology; D002308:Cardiolipins / Q000378:metabolism; D002311:Cardiomyopathy, Dilated / Q000235:genetics* / Q000473:pathology; D018389:Codon, Nonsense; D005091:Exons; D018740:Genetic Heterogeneity; D005977:Glutarates / Q000652:urine; D006330:Heart Defects, Congenital / Q000235:genetics* / Q000473:pathology; D006333:Heart Failure / Q000235:genetics* / Q000473:pathology; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D009503:Neutropenia / Q000235:genetics / Q000473:pathology; D010375:Pedigree; D014157:Transcription Factors / Q000235:genetics*
chemical_list: D002308:Cardiolipins; D018389:Codon, Nonsense; D005977:Glutarates; D014157:Transcription Factors; C022034:3-methylglutaconic acid; D000217:Acyltransferases; C108675:TAFAZZIN protein, human